Patients Aged ≥ 70 Are at High Risk for Neutropenic Infection and Should Receive Hemopoietic Growth Factors When Treated With Moderately Toxic Chemotherapy-Reference-Cited by-同舟云学术

Patients Aged ≥ 70 Are at High Risk for Neutropenic Infection and Should Receive Hemopoietic Growth Factors When Treated With Moderately Toxic Chemotherapy

Published:2001-03-01 Issue:5 Volume:19 Page:1583-1585
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Balducci Lodovico,Lyman Gary H.,Ozer Howard

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2001.19.5.1583

Reference19 articles.

1. 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines

2. ANTINEOPLASTIC CHEMOTHERAPY OF THE OLDER CANCER PATIENT

3. Zinzani PG, Storti S, Zaccaria A, et al: Elderly aggressive histology non-Hodgkin’s lymphoma: First line VNCOP-B regimen—Experience on 350 patients. Blood 94: 33,1999-38,

4. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.

5. Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Splenic and PB immune recovery in neoadjuvant treated gastrointestinal cancer patients;International Immunopharmacology;2022-05

2. Patterns of primary prophylactic granulocyte colony-stimulating factor use in older Medicare patients with cancer receiving myelosuppressive chemotherapy;Supportive Care in Cancer;2022-04-28

3. Medication therapy in older adults;Atkinson's Principles of Clinical Pharmacology;2022

4. Filgrastim prophylaxis in elderly cancer patients in the real-life setting: a French multicenter observational study, the TULIP study;Supportive Care in Cancer;2019-03-14

5. The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment;International Journal of Radiation Oncology*Biology*Physics;2017-07